Return On Equity of Aptevo Therapeutics Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aptevo Therapeutics Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Aptevo Therapeutics Inc. Return On Equity for the quarter ending 30 Sep 2025 was -389%, a 12% decline year-over-year.
  • Aptevo Therapeutics Inc. annual Return On Equity for 2024 was -489%, a 366% decline from 2023.
  • Aptevo Therapeutics Inc. annual Return On Equity for 2023 was -105%, a 266% decline from 2022.
  • Aptevo Therapeutics Inc. annual Return On Equity for 2022 was 63%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Aptevo Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -389% -41% -12% 01 Jul 2025 30 Sep 2025
Q2 2025 -676% -409% -154% 01 Apr 2025 30 Jun 2025
Q1 2025 -779% -560% -256% 01 Jan 2025 31 Mar 2025
Q4 2024 -489% -384% -366% 01 Oct 2024 31 Dec 2024
Q3 2024 -349% -259% -290% 01 Jul 2024 30 Sep 2024
Q2 2024 -266% -171% -179% 01 Apr 2024 30 Jun 2024
Q1 2024 -219% -312% -337% 01 Jan 2024 31 Mar 2024
Q4 2023 -105% -168% -266% 01 Oct 2023 31 Dec 2023
Q3 2023 -89% -164% -219% 01 Jul 2023 30 Sep 2023
Q2 2023 -95% -205% -187% 01 Apr 2023 30 Jun 2023
Q1 2023 92% +793% 01 Jan 2023 31 Mar 2023
Q4 2022 63% +409% 01 Oct 2022 31 Dec 2022
Q3 2022 75% +317% 01 Jul 2022 30 Sep 2022
Q2 2022 110% +379% 01 Apr 2022 30 Jun 2022
Q1 2022 -700% -406% -138% 01 Jan 2022 31 Mar 2022
Q4 2021 -346% -179% -108% 01 Oct 2021 31 Dec 2021
Q3 2021 -242% -43% -21% 01 Jul 2021 30 Sep 2021
Q2 2021 -269% -132% -96% 01 Apr 2021 30 Jun 2021
Q1 2021 -294% -154% -110% 01 Jan 2021 31 Mar 2021
Q4 2020 -167% +0.27% +0.16% 01 Oct 2020 31 Dec 2020
Q3 2020 -199% -39% -24% 01 Jul 2020 30 Sep 2020
Q2 2020 -137% +12% +7.9% 01 Apr 2020 30 Jun 2020
Q1 2020 -140% -18% -14% 01 Jan 2020 31 Mar 2020
Q4 2019 -167% -59% -55% 01 Oct 2019 31 Dec 2019
Q3 2019 -161% -82% -104% 01 Jul 2019 30 Sep 2019
Q2 2019 -149% -150% -10065% 01 Apr 2019 30 Jun 2019
Q1 2019 -122% -127% -3016% 01 Jan 2019 31 Mar 2019
Q4 2018 -108% -118% -1205% 01 Oct 2018 31 Dec 2018
Q3 2018 -79% -82% -2897% 01 Jul 2018 30 Sep 2018
Q2 2018 1.5% +191% 01 Apr 2018 30 Jun 2018
Q1 2018 4.2% +165% 01 Jan 2018 31 Mar 2018
Q4 2017 9.8% +159% 01 Oct 2017 31 Dec 2017
Q3 2017 2.8% +139% 01 Jul 2017 30 Sep 2017
Q2 2017 -190% 01 Apr 2017 30 Jun 2017
Q1 2017 -160% 01 Jan 2017 31 Mar 2017
Q4 2016 -149% 01 Oct 2016 31 Dec 2016
Q3 2016 -136% 01 Jul 2016 30 Sep 2016

Aptevo Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -489% -384% -366% 01 Jan 2024 31 Dec 2024
2023 -105% -168% -266% 01 Jan 2023 31 Dec 2023
2022 63% +409% 01 Jan 2022 31 Dec 2022
2021 -346% -179% -108% 01 Jan 2021 31 Dec 2021
2020 -167% +0.27% +0.16% 01 Jan 2020 31 Dec 2020
2019 -167% -59% -55% 01 Jan 2019 31 Dec 2019
2018 -108% -118% -1205% 01 Jan 2018 31 Dec 2018
2017 9.8% +159% 01 Jan 2017 31 Dec 2017
2016 -149% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.